Degenerate antigen recognition by CD4 + effector T cells in experimental autoimmune encephalomyelitis

Abstract

Peptide-specific tolerance with PLP139–151 peptide analogs was used to compare the fine antigen-specificity requirements at both the inductive and effector phases of relapsing EAE (R-EAE). A PLP139–151 analog peptide containing a single substitution at the primary T cell receptor (TcR) contact residue (A144) did not induce proliferation in PLP139–151-primed CD4 + T cells. In addition, tolerance induced with ECDI-treated, A144-coupled splenocytes failed to prevent the inductive phase of PLP139–151-induced R-EAE or to inhibit the induction of peptide-specific DTH indicating that naive PLP139–151-specific T cells do not react with the A144 peptide analog. In contrast, A144-coupled splenocytes did prevent the expression of the effector phase of R-EAE and inhibited the elicitation of peptide-specific DTH responses upon administration to mice seven days after immunization with PLP139–151. The results provide in vivo evidence that `antigen-experienced' T cells recognize a broader repertoire of antigens than do naive T cells and have important implications for the regulation of immune responses and for advancing our understanding of the pathogenesis and treatment of autoimmune disease.